BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance ...

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy. The offerings span the globe ...

PAREXEL International Corporation has announced three new academic programmes at the PAREXEL Academy. The offerings span the globe and are designed to prepare students for careers in the ...

BOSTON & TOKYO--(BUSINESS WIRE)--PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, and Meiji Pharmaceutical University (MPU), a private pharmacy and ...

PAREXEL International Corporation (PRXL), a leading global biopharmaceutical services provider, and Kyoto Pharmaceutical University (KPU), a private pharmacy and science university, today announced ...

US-based bio/pharmaceutical services organisation Parexel International is addressing the growing demand for new talent to underpin the rapid expansion of clinical research in Asia by setting up an ...

US-based biopharmaceutical services provider Parexel International has formed a public-private partnership with Salem State University in Massachusetts to offer a Post Graduate Certificate programme ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. With a new academic partner in Meiji Pharmaceutical ...

COVID-19 completely disrupted the work ecosystem and the expectations that employers and employees have from the workplace. With an increase in the number of jobs, roles, and remote and hybrid work ...

Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, today announced an innovative partnership with ...